Showing 21 - 40 results of 196 for search '"lorazepam"', query time: 0.08s Refine Results
  1. 21
  2. 22
  3. 23
  4. 24
  5. 25
  6. 26
  7. 27
  8. 28
  9. 29
  10. 30
  11. 31

    Successful Treatment of Irinotecan-Induced Muscle Twitching: A Case Report by Yu-Ting Shun, Hsien-Yung Lai, Yi-Ting Chuang, Hsuen-Fu Lin

    Published 2023-01-01
    “…Benzodiazepine agonists, such as lorazepam, is the potential treatment of choice.…”
    Get full text
    Article
  12. 32

    Catatonia, Pregnancy, and Electroconvulsive Therapy (ECT) by Khushbu Gandhi, KieuHanh Nguyen, Maggie Driscoll, Zahid Islam, Siddhartha Maru

    Published 2023-01-01
    “…While initially, the patient appeared to have a positive response to lorazepam, she became increasingly catatonic with minimal oral intake, mutism, and urinary retention. …”
    Get full text
    Article
  13. 33

    Negative emotionality downregulation affects moral choice but not moral judgement of harm: a pharmacological study by Roger Marcelo Martinez, Shih-Han Chou, Yang-Teng Fan, Yu-Chun Chen, Kah Kheng Goh, Chenyi Chen

    Published 2024-01-01
    “…Furthermore, using another sample (Study 2, N = 31), we assess whether lorazepam’s effect is modulated by different perspective-taking conditions during a moral dilemma task –e.g. …”
    Get full text
    Article
  14. 34

    Management and outcomes of catatonia: A prospective study in urban South Africa by Zukiswa Zingela, Louise Stroud, Johan Cronje, Max Fink, Stephan van Wyk

    Published 2022-06-01
    “…Treatment guidelines for catatonia need to include the role and timing of electroconvulsive therapy to augment current treatment protocols for the use of lorazepam.…”
    Get full text
    Article
  15. 35

    Jasmine essential oil promotes delta-beta power activities in the dorsal hippocampus under slow wave sleep promotion by Dania Cheaha, Nurulhuda Basor, Nusaib Sa-i, Ekkasit Kumarnsit, Anthony Chaikul, Nifareeda Samerphob

    Published 2023-02-01
    “…Adult male Swiss Albino (ICR) mice treated with distilled water, jasmine essential oil and lorazepam administration were assessed for sleep stages offline from the dorsal hippocampal brain activity. …”
    Get full text
    Article
  16. 36

    Assessment of Treatment Patterns in Patients with Alcohol Withdrawal Syndrome during Hospitalisation and Post-discharge: A Retrospective Cohort Study by Nilesh Shah, Sagar Karia, Mahesh Gowda, Gorav Gupta, Snehanshu Dey, Phani Prasant Mulakaluri, Aninda Sidana, Shailesh Pangaonkar

    Published 2023-09-01
    “…During post-discharge treatment, 57.0% (n/N=74/130) of patients received lorazepam, while 52.0% (n/N=67/130) received chlordiazepoxide. …”
    Get full text
    Article
  17. 37

    An Emulation of Randomized Trials of Administrating Benzodiazepines in PTSD Patients for Outcomes of Suicide-Related Events by Michael Gilbert, Andrew Dinh La, Noah Romulo Delapaz, William Kenneth Hor, Peihao Fan, Xiguang Qi, Xiaojiang Guo, Jian Ying, Lirong Wang

    Published 2020-10-01
    “…Head-to-head comparisons identified that patients who received alprazolam had fewer SRBs compared to clonazepam (<i>p</i> = 0.0351) and lorazepam (<i>p</i> = 0.0373), and patients taking midazolam experienced fewer relative incidences of SRBs when compared to lorazepam (<i>p</i> = 0.0021) and clonazepam (<i>p</i> = 0.0297). …”
    Get full text
    Article
  18. 38

    A rare case of recurrent psychosis with hypothyroidism precipitating catatonia by Poojitha Reddy Konda, Suresh Reddy, Surekha Gunde

    Published 2023-01-01
    “…After being diagnosed with catatonia, 2 mg of lorazepam was administered intravenously, and after 10 min, she began speaking. …”
    Get full text
    Article
  19. 39

    Catatonia as a Result of a Traumatic Brain Injury by Jessica Berthelot, Jacob Cambre, Madeline Erwin, Jennifer Phan

    Published 2024-01-01
    “…After being admitted with the diagnosis of postconcussive syndrome, he was ultimately diagnosed with catatonia, and intravenous lorazepam resulted in a return to his baseline mental status. …”
    Get full text
    Article
  20. 40

    5HT-3 RECEPTOR BLOCKADE IN NICOTINE WITHDRAWAL - STUDY WITH BRL 46470A by Park, S, Smith, A, Cowen, P

    Published 1993
    “…The study was of a double-blind, placebo-controlled, four-way crossover design using two doses of BRL 46470A (0.1 and 10 μg) and one dose of lorazepam (1 mg). Outcome measures included visual analogue ratings for nicotine withdrawal and a battery of psychological performance tests. …”
    Journal article